Company Snapshot: BSTE  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Biosite Announces Presentation at the JPMorgan 2006 Small/Mid Cap Conference

    SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- Biosite(R) Incorporated
(Nasdaq: BSTE) today announced that Chris Twomey, senior vice president,
finance and chief financial officer, and Gunars Valkirs, Ph.D., senior vice
president, Biosite Discovery, will discuss the Company's operating
environment, products and research and development activities at the
JPMorgan 2006 Small/Mid Cap Conference. The conference will be held at the
Four Seasons Hotel in Boston. Biosite's presentation will take place
November 15, 2006, at 8:45 a.m. Eastern Standard Time.
    A link to the live audio webcast can be accessed through the Biosite
website, http://www.biosite.com. The Biosite presentation will be archived on the
website until December 6, 2006 in the Investor Center under Events
Calendar.
    About Biosite Incorporated
    Biosite(R) Incorporated is a leading bio-medical company
commercializing proteomics discoveries for the advancement of medical
diagnosis. The Company's products contribute to improvements in medical
care by aiding physicians in the diagnosis of critical diseases and health
conditions. Biosite's Triage(R) rapid diagnostics are used in approximately
50 percent of U.S. hospitals and in more than 60 international markets.
Information on Biosite can be found at http://www.biosite.com.
    Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a trademark of
Biosite Incorporated.


SOURCE Biosite Incorporated




Back to Topback to top

Related links:
  • http://www.biosite.com
  • http://www.prnewswire.com/comp/116737.html /
    CONTACT:
    Nadine Padilla, Vice President, Corporate and
    Investor Relations of Biosite Incorporated, +1-858-805-2820,
    npadilla@biosite.com